Overview

Combined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMD

Status:
Unknown status

Trial end date:
2006-11-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy and safety of photodynamic therapy (PDT) combined with intravitreal bevacizumab versus combination of photodynamic therapy , intravitreal bevacizumab and intravitreal triamcinolone for neovascular AMD.

Phase:

Phase 3

Details

Lead Sponsor:

Shahid Beheshti University of Medical Sciences

Treatments:

Bevacizumab
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Verteporfin